DAIC

APRIL 12, 2024

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

DAIC

FEBRUARY 20, 2024

mm (green outline) section thickness show the respective calcified plaque (arrowheads) and coronary stenosis (inset images). The technology has the potential to improve patient management and reduce unnecessary interventions. No substantial benefits of ultrahigh-spatial-resolution were observed for mixed and non-calcified plaques. “It

Coronary Artery Disease 105

Coronary Artery Disease Stenosis Plaque Technology 105

DAIC

NOVEMBER 8, 2024

Developing and driving clinical evidence is crucial to improving care and guiding the adoption of new technologies like the Philips laser atherectomy and lithotripsy system,” said Drs. The care team there successfully treated a 78-year-old male with peripheral vascular disease using the Philips device.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

DAIC

MARCH 1, 2024

ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. Following Breakthrough Device Designation granted for the technology by the FDA in 2021, the approval was supported by positive results from the multicenter, prospective, randomized controlled AGENT IDE trial , which enrolled 600 patients at 40 U.S.

Stent 105

Stent Stents Coronary Artery Disease Angioplasty 105

DAIC

JANUARY 23, 2024

Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” HeartFlow remains dedicated to reshaping cardiovascular care and ensuring that hospitals have access to comprehensive, accurate, and efficient solutions in precision coronary care.

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

Open Heart

FEBRUARY 16, 2023

In many cases, plaque preparation is a critical prerequisite for delivery of devices across calcific stenoses and also to achieve adequate luminal dimensions. Recent advances in intracoronary imaging and adjunctive technologies now allow the operator to select the most appropriate strategy in each individual case.

Plaque 52

Plaque Technology 52

DAIC

OCTOBER 1, 2024

tim.hodson Tue, 10/01/2024 - 10:50 PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy, showing specific plaque type and amount across various views to inform physician assessment of risk and patient-specific treatment pathway.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

Stroke Journal

JANUARY 21, 2024

The mechanisms by which ICAD causes stroke include plaque rupture with in situ thrombosis and occlusion or artery-to-artery embolization, hemodynamic injury, and branch occlusive disease. In fact, the 1-year recurrent stroke rate of >20% among those with stenosis >70% is one of the highest rates among common causes of stroke.

Stenosis 74

Stenosis Thrombosis Dementia Stroke 74

DAIC

JANUARY 3, 2024

7 While HeartFlow was founded with FFR CT technology, the company has evolved from a single product used to assess the impact that narrowing vessels have on coronary blood flow (FFR CT Analysis), to a comprehensive suite of non-invasive technologies that build on CCTA. said John Farquhar, Chief Executive Officer at HeartFlow.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

FEBRUARY 13, 2024

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. With Plaque Features Associated with False Positives.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

DECEMBER 16, 2024

For PAD, the clot-sensing technology is being developed to instantly identify fresh clot and differentiate it from organized clot thrombus poor in RBCs as well as plaque, calcium and other tissue in real-time to inform individualized PAD treatment. we aspirate, dissolve the clot, or use another method?

Peripheral Arterial Disease 52

Peripheral Arterial Disease Technology Plaque Stroke 52

ADN Center of Excellence

NOVEMBER 20, 2023

As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). OCT employs light waves to capture high-resolution images, providing intricate details of vessel structures and plaque composition.

Interventional Cardiology 52

Interventional Cardiology Education Technology Ultrasound 52

Journal of the American Heart Association

JANUARY 12, 2024

Irradiation of 282 nm UV‐B but not 301 or 312 nm UV‐B significantly reduced the development of aortic root atherosclerotic plaques and plaque inflammation.

Atherosclerosis 45

Atherosclerosis Plaque Aortic Technology 45

Circulation

DECEMBER 17, 2024

Natural compound libraries were screened to identify potent METTL4 antagonists. Pemetrexed was identified as the first METTL4 antagonist to effectively alleviate atherosclerotic progression.

Atherosclerosis 40

Atherosclerosis Transplant Plaque Pharmacology 40

ADN Center of Excellence

JUNE 11, 2024

At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.

Innovation 52

Innovation Quality of Life Cancer Technology 52

ADN Center of Excellence

JUNE 11, 2024

At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.

Innovation 52

Innovation Quality of Life Cancer Technology 52

ADN Center of Excellence

SEPTEMBER 27, 2023

Why IVUS and OCT Are Vital These technologies aren't just extras; they are the ticket to enhanced diagnostic accuracy and improved patient results. IVUS reveals plaque characteristics, optimal stent usage, and vessel measurements. Meanwhile, OCT employs light waves to capture tiny vessel wall details.

Education 52

Education Best Practices Stent Stents 52

ADN Center of Excellence

NOVEMBER 20, 2023

As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). OCT employs light waves to capture high-resolution images, providing intricate details of vessel structures and plaque composition.

Interventional Cardiology 40

Interventional Cardiology Education Technology Ultrasound 40

Circulation

NOVEMBER 11, 2024

eGC shedding could contribute to atherosclerotic plaque vulnerability and acute myocardial infarction (AMI) installation. The integrity of this structure sustains some vascular properties such as shear stress-induced nitric oxide release and the prevention of platelets and neutrophils adhesion on the vessel surface.

Myocardial Infarction 40

Myocardial Infarction Plaque Technology Diabetes 40

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) A Selective Aldose Reductase Inhibitor (at-001) For the Treatment of Diabetic Cardiomyopathy: Primary Results of the Phase 3 Randomized Controlled ARISE-HF Study Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results of IMPROVE-HCM Topical (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. Smith's ECG Blog

MARCH 28, 2017

She was treated medically for NonSTEMI, pending next day cath, which showed ulcerated plaque and a 60% thrombotic stenosis in the LAD distal to the first diagonal. Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. Regional wall motion abnormality-distal septum and apex. It was stented.

STEMI 40

STEMI Risk Factors Bicuspid/Mitral Ultrasound 40

DAIC

MARCH 27, 2024

a leader in AI-driven healthcare technology, announced the launch of the DECIDE Registry, the largest prospective registry of its kind, with the first site initiated, Cone Health Care. 2 “Data from the DECODE study shows the value of using Plaque Analysis. 2 “Data from the DECODE study shows the value of using Plaque Analysis.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

DAIC

MARCH 11, 2025

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed tomography angiography (CCTA) scans to determine the presence, extent and severity of coronary plaques and luminal stenosis (narrowing of arteries). But with AI, we can change that.

Plaque 52

Plaque Heart Attack Heart attacks Technology 52

Science Daily - Heart Disease

SEPTEMBER 18, 2024

A team developed a nanoparticle technology that offers an effective solution to diagnose and treat atherosclerosis, in a non-invasive manner.

Atherosclerosis 114

Atherosclerosis Technology Research Plaque 114

DAIC

DECEMBER 5, 2024

The company’s advanced non-invasive computed tomography (CT) imaging technology enables comprehensive phenotyping of coronary artery disease, grounded in scientific research based on millions of medical images. Until Cleerly, healthcare providers have had no way to easily and completely assess plaque burden in a non-invasive manner.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

JULY 18, 2024

This registry will aim to provide world-wide physicians the most accurate information on coronary plaque to improve cardiovascular risk prediction and support the selection of patient-specific treatment,” said Dr. De Cecco. Márton Kolossváry (Gottsegen National Cardiovascular Center, Budapest, Hungary).

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

Dr. Smith's ECG Blog

OCTOBER 23, 2022

She was treated medically for NonSTEMI, pending next day cath, which showed ulcerated plaque and a 60% thrombotic stenosis in the LAD distal to the first diagonal. Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. Regional wall motion abnormality-distal septum and apex. It was stented.

STEMI 40

STEMI Chest Pain Hospital Risk Factors 40

DAIC

FEBRUARY 26, 2025

a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. tim.hodson Wed, 02/26/2025 - 10:24 Feb. 25, 2025 Heartflow, Inc. , In the U.S.,

Coronary Artery Disease 59

Coronary Artery Disease Heart Attack Heart attacks Technology 59

DAIC

MAY 23, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging. milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. ,

Plaque 52

Plaque Coronary Artery Disease Technology Anatomy 52

DAIC

MARCH 20, 2024

Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.

Technology 111

Technology Coronary Artery Disease Patient Care Private Practice 111

MIBHS

FEBRUARY 28, 2025

Specific genetic variants, such as those affecting cholesterol metabolism, can increase the likelihood of plaque buildup in the arteries. Gene-based therapies and interventions, such as gene editing technologies, show potential in treating hereditary conditions, although these treatments are still in early stages.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

JANUARY 25, 2024

mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease. mg tablets.”

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

DAIC

JUNE 4, 2024

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.

Stent 111

Stent Stents Research Stroke 111

DAIC

MAY 8, 2024

2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. 5 Revascularization to improve blood flow to the heart has been shown to reduce mortality in stable chest pain patients.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

DAIC

FEBRUARY 8, 2024

Zixiao Li added, “This type of technology aids neurologists by facilitating the sharing of information between humans and AI, using their combined strengths.” 87% of strokes are ischemic strokes, which occur when blood vessels to the brain become narrowed or clogged with plaque, cutting off blood flow to the brain. In the U.S.,

Research 105

Research Stroke Strokes Heart Attack 105

Dr. Paddy Barrett

AUGUST 1, 2023

Historically, the radiation required to perform CTCA scans was relatively high, but with the advent of newer scanning technologies, that dose has been significantly reduced 1. A CTCA provides much more anatomical detail and can identify advanced plaque often missed by CT Coronary Artery Calcium Score scans alone.

Coronary Angiogram 52

Coronary Angiogram Plaque Coronary Artery Disease Chest Pain 52